Launch of Major Resource at ISMPO Congress

Overview of the Congress

The Indian Society of Medical and Pediatric Oncology (ISMPO) Congress recently took place in Jaipur, where a significant new resource was unveiled. The publication, titled *Early Breast Cancer: Evidence-Based Diagnosis and Treatment*, serves as a comprehensive, multidisciplinary guide dedicated to the management of early-stage breast cancer.

About the Book

Edited by Dr. Hemant Malhotra and published by Springer Nature India Private Limited, this book presents a globally relevant approach while focusing on the unique context of India. It consolidates current evidence, evolving treatment strategies, and practical clinical guidance across 14 chapters, contributed by 23 distinguished medical experts and oncologists.

Key Contributions and Chapters

The book opens with a thorough overview of breast cancer epidemiology and trends by Dr. Indoo Ammbulkar, who highlights the increasing incidence of breast cancer both globally and within India.

Dr. Jaishree Goyal presents a detailed analysis of screening guidelines and recommendations, comparing both global and Indian protocols.

Dr. Roshni Bhagwat Pande discusses the integration of artificial intelligence in breast cancer screening, focusing on advancements in mammography and MRI that facilitate earlier detection of lesions.

The paradigm shift from radical mastectomy to breast-conserving surgery and sentinel lymph node biopsy is explored by Dr. Archit Joshi, Dr. Hemanth Kumar, and Dr. L.P. Bhaskar Bhuvan, who also delve into neoadjuvant therapies for early breast cancer.

Dr. Adhip Arora, Dr. Mounika Pallati, and Dr. Atul Batra provide an extensive overview of chemotherapy, endocrine therapy, targeted therapies, and immunotherapy tailored for early-stage breast cancer. The impact of these therapies on hormone receptor-positive breast cancer is discussed by Dr. Ajay Yadav, Dr. Hemant Malhotra, and Dr. Chhavi Goyal.

Dr. Nitin Khunteta emphasizes the significance of sentinel lymph node biopsy (SLNB) in evaluating axillary nodal involvement.

Dr. Aniket Goenka addresses the management of breast cancer in special populations, including elderly patients, men diagnosed with breast cancer, and cases associated with pregnancy. Dr. Raja Pramanik examines genetic and hereditary factors, highlighting the role of multigene panel testing in identifying high-risk individuals and personalizing treatment plans.

Holistic Care and Survivorship

The book also covers psychological support and nutritional guidance, with insights from Dr. Arati Hota and Dr. Vineeta Bansal, who stress the importance of a holistic care approach for cancer patients throughout their treatment journey.

Dr. TVSVGK Tilak discusses the long-term effects of cancer treatments, offering strategies to manage the health and quality of life for breast cancer survivors.

Additionally, Dr. Satyajit Soni and Dr. Arpit Jain address targeted therapy and future directions in early breast cancer treatment, emphasizing the necessity of supportive care and survivorship planning.

Dr. Geeta Kadayaprath, Dr. Preeti Grewal, and Dr. Shreya Chopra provide practical insights into the evolution of breast cancer surgery, focusing on the role of innovative techniques and technologies in enhancing surgical outcomes.

Accessing the Book

To access the book, scan the QR Code or click on the following link: [Early Breast Cancer: Evidence-Based Diagnosis and Treatment](https://theedumed.com/early-breast-cancer/).

Contact Information for Eli Lilly and Company

For further information regarding Lilly and its products, please contact:
Plot 92, Sector 32, Gurgaon, Haryana, 122001, India
Phone: +91-124-4753000/01
Website: www.lilly.com/in

For adverse event reporting, reach out to: [email protected].
For additional inquiries related to Lilly products, please contact: [email protected].

This material is intended solely for the use of the recipient(s) and may contain confidential information. Unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please notify the sender immediately and destroy all copies of the material. The information provided is solely for registered medical practitioners and should not be construed as medical advice or recommendations regarding health-related decisions.

Lilly India Privacy Policy

© 2025 Eli Lilly and Company